Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)

Denosumab as part of neoadjuvant therapy, although not improving the pCR rate, significantly reduced the risk of distant relapses. Other long-term outcome parameters did not differ between the treatment arms. TNBC patients, especially when not achieving pCR, seem to benefit from weekly nPac.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-11-27
DOI
https://doi.org/10.1016/j.esmoop.2025.105915
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)

J. Huober, Johannes Holtschmidt, M. Just, Theresa Link et al.
ESMO Open
Bone health and treatments
article

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)

J. Huober, Johannes Holtschmidt, M. Just, Theresa Link, Peter A. Fasching, Christine Solbach, Natalie Filmann, Vesna Bjelic‐Radisic, Claus Hanusch, Jens‐Uwe Blohmer, M. Untch, Carsten Denkert, Knut Engels, Pauline Wimberger, Mattea Reinisch, Marc Thill, Valentina Nekljudova, Sibylle Loibl, Andreas Schneeweiß, Oliver Stötzer, Kerstin Rhiem
article en

Abstract

Denosumab as part of neoadjuvant therapy, although not improving the pCR rate, significantly reduced the risk of distant relapses. Other long-term outcome parameters did not differ between the treatment arms. TNBC patients, especially when not achieving pCR, seem to benefit from weekly nPac.

ESMO OpenVol. 10(12)
Goethe University Frankfurt (DE), Philipps University of Marburg (DE), German Cancer Research Center (DE), Heidelberg University (DE), Universitätsklinikum Gießen und Marburg (DE), Kantonsspital St. Gallen (CH), University Hospital Heidelberg (DE), National Center for Tumor Diseases (DE), Helios Universitätsklinikum Wuppertal (DE), German Breast group (DE), University Hospital Frankfurt (DE), Praxis für Hämatologie und Onkologie (DE), Rotkreuzklinikum München (DE), Agaplesion Markus Hospital (DE), Centrum für Integrierte Onkologie (DE), Comprehensive Cancer Center Erlangen (DE), University Hospital Cologne (DE), Helios Hospital Berlin-Buch (DE), University Medical Centre Mannheim (DE), University Hospital Carl Gustav Carus (DE), Zentrum für Pathologie und Zytodiagnostik (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 49%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.